在德语国家胆碱能性荨麻疹患者的现实生活治疗

JDDG: Journal der Deutschen Dermatologischen Gesellschaft Pub Date : 2019-11-01 DOI:10.1111/ddg.13979

Emilia Mellerowicz, K. Weller, T. Zuberbier, M. Maurer, S. Altrichter

{"title":"在德语国家胆碱能性荨麻疹患者的现实生活治疗","authors":"Emilia Mellerowicz, K. Weller, T. Zuberbier, M. Maurer, S. Altrichter","doi":"10.1111/ddg.13979","DOIUrl":null,"url":null,"abstract":"Cholinergic urticaria (CholU) is a frequent type of chronic inducible urticaria. Symptomatic treatment with second‐generation antihistamines (sgAH) is recommended by current guidelines as first‐line therapy, but little is known about how patients with CholU are treated in real life and how they respond to treatment.","PeriodicalId":14702,"journal":{"name":"JDDG: Journal der Deutschen Dermatologischen Gesellschaft","volume":"33 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"10","resultStr":"{\"title\":\"Real‐life treatment of patients with cholinergic urticaria in German‐speaking countries\",\"authors\":\"Emilia Mellerowicz, K. Weller, T. Zuberbier, M. Maurer, S. Altrichter\",\"doi\":\"10.1111/ddg.13979\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Cholinergic urticaria (CholU) is a frequent type of chronic inducible urticaria. Symptomatic treatment with second‐generation antihistamines (sgAH) is recommended by current guidelines as first‐line therapy, but little is known about how patients with CholU are treated in real life and how they respond to treatment.\",\"PeriodicalId\":14702,\"journal\":{\"name\":\"JDDG: Journal der Deutschen Dermatologischen Gesellschaft\",\"volume\":\"33 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"10\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JDDG: Journal der Deutschen Dermatologischen Gesellschaft\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1111/ddg.13979\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JDDG: Journal der Deutschen Dermatologischen Gesellschaft","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1111/ddg.13979","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 10

摘要

胆碱能性荨麻疹(CholU)是一种常见的慢性诱导型荨麻疹。目前的指南推荐使用第二代抗组胺药(sgAH)作为一线治疗，但对于CholU患者在现实生活中如何治疗以及他们对治疗的反应知之甚少。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Real‐life treatment of patients with cholinergic urticaria in German‐speaking countries

Cholinergic urticaria (CholU) is a frequent type of chronic inducible urticaria. Symptomatic treatment with second‐generation antihistamines (sgAH) is recommended by current guidelines as first‐line therapy, but little is known about how patients with CholU are treated in real life and how they respond to treatment.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

JDDG: Journal der Deutschen Dermatologischen Gesellschaft

自引率

0.00%

发文量